Accueil > Revues > Biologie et recherche > Magnesium Research > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
Biologie et recherche
Magnesium Research
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable
  Version PDF

The effect of preoperative magnesium supplementation on blood catecholamine concentrations in patients undergoing CABG


Magnesium Research. Volume 19, Numéro 2, 113-22, June 2006, Original article


Summary  

Auteur(s) : Kazimierz Pasternak, W Dąbrowski, J Dobija, J Wrońska, Z Rzecki, J Biernacka , Department of General Chemistry, Department of Anaesthesiology and Intensive Therapy Feliks Skubiszewski Medical University of Lublin, Poland.

Illustrations

ARTICLE

Auteur(s) : Kazimierz Pasternak1, W Dąbrowski2, J Dobija1, J Wrońska1, Z Rzecki2, J Biernacka2

1Department of General Chemistry
2Department of Anaesthesiology and Intensive Therapy Feliks Skubiszewski Medical University of Lublin, Poland

Electrolyte disorders and their relationship with hormonal balance are one of the main subjects of clinical investigations [1, 2]. In some cases this problem is important, e.g. particularly in haemodynamically unstable patients undergoing surgical myocardial revascularization. The complex character of extracorporeal circulation (ECC) as well as the intraoperative therapy used may affect electrolyte and hormonal balance and lead to its disorders. Among them are disorders of blood magnesium concentration.It is well known that magnesium (Mg) plays a significant role in cell physiology and its deficiency may cause many disorders which often require intensive treatment. The physiological level of Mg in blood serum ranges from 0.8 to 1.2 mmol/L – 24 % combined with proteins, 10 % in complexes and 65 % in the ionized form. It is worth stressing that even the smallest changes in Mg concentration in blood serum are reflected in its intracellular level, which, in turn, affects cellular function [3]. Moreover, even temporary or secondary deficiency of this element is likely to lead to significant clinical dysfunction of various organs and aggravate or alter the clinical picture of any underlying disease. Therefore, many researchers underline the role of normomagnesemia, especially in patients with myocardial pathology [4, 5]. Dysfunction of the myocardium is mostly associated with abnormal irritability and conductivity of the stimulus-transmitting system, which initially manifests itself on ECG as longer P-R and Q-T intervals, and, at higher degrees of deficiency, as tachycardia, atrial fibrillation, premature ventricular contractions and as ventricular fibrillation in extreme cases.On the other hand Mg plays an important role in the regulation of blood concentration of catecholamines, particularly epinephrine (E) and norepinephrine (NE). Any deficiency of blood Mg concentration results in hypercatecholaminemia followed by hypersensitization of the myocardial cells.This problem is particularly relevant in patients subjected to cardiosurgical procedures with ECC [6]. The complex nature of such procedures, especially intraoperative normovolemic haemodilution, may alter blood Mg levels, which is likely to result in the dysfunction of various organs, particularly postoperatively stunned myocardium.The aim of this study was to analyze the influence of pre-operative magnesium supplementation on blood epinephrine and norepinephrine concentrations in patients undergoing surgical myocardial revascularization.

Patients and methods

The study was approved by the Bioethical Committee of Medical University of Lublin (No KE-0254/244/2000) and included the patients who underwent operations due to I° and II° coronary disease (according to CCS). Exclusion criteria were: any endocrinological, neurological or metabolic disease, myocardial infarction in last 6 months before surgery and lack of patient’s consent.

The patients underwent general anaesthesia with fentanyl, midazolam and etomidat. Muscle relaxation was obtained by injecting a single dose of pancuronium. The anaesthesia was maintained throughout the procedure using midazolam-fentanyl infusion and inhalatory fractionated doses of foran. During the implantation of aorto-coronary bypasses the circulation and ventilation were maintained by the heart-lung machine S III (Stockert). The following substances were used for priming: Ringer’s solution, 6 % solution of hydroxyethylated starch (HAES), 20 % mannitol, sodium hydroxycarbonate, and heparin. The same priming was used for all patients (without Mg). Cardioplegia was prepared using 0.9 % salt solution supplemented with 3g of potassium chloride (Kalium chloratum, Polfa, Pl) and 20 mL of sodium hydroxycarbonate.

The patients were randomly divided into 2 groups: A – the patients receiving pre-operative Mg supplementation and B – patients without pre-operative Mg supplementation. During the surgery and in the early postoperative period (zero postoperative day) all patients received potassium chloride 250 mg/h and Mg sulfate 200 mg/h.

Immediately after surgery all patients were transferred to the Postoperative Intensive Care Unit (PICU) where they received a short-term infusion of 5 % glucose solution with insulin.

The blood specimens were obtained in 5 stages: 1) before anesthesia after the radial artery cannulation, 2) during normowolemic haemodilution and ECC, 3) immediately after surgery, 4) in the morning of the 1st postoperative day, 5) in the morning of the 2nd postoperative day.

The blood samples were collected from the radial artery and immediately centrifuged (25000 r/min., temp. 0°C); the obtained serum was frozen at - 20°C. The Mg were determined by spectrophotometric methods. The E and NE were measured by radioimmunoassay methods.

The results were statistically analysed using Kruskall – Wallis and Friedman test for initial detection of differences, and Wilcoxon signed rank test, Mann-Whitney U and Spearman rank correlation tests for interstage and intergroup comparisons. Since data histograms showed skewed distributions nonparametric methods of analysis were chosen.

Results

Forty men aged 50-72 (66.2 ± 7.5) were studied. Twenty-eight patients had myocardial infarction during the past 3 years and thirty five were treated due to concomitant arterial hypertension (I° or II° according to WHO classification). None of the patients was treated for endocrinological, neurological and other systemic disease nor was resuscitated because of circulatory arrest. The mean duration of the procedure was 189.2 min ± 32 and of anaesthesia 205 min. ± 40.

In all the patients the aorta was typically clamped and the mean closure time was 37.2 min. ± 12.5. The aorto-coronary anastomosis was performed in mild hypothermia of 35.2 °C ± 0.4. In all the cases weaning from the heart-lung machine was uneventful and there was no need of intra-aortic contrapulsation.

The mean blood Mg concentration in group A before surgery was 1.03 mmol/L. The initiation of cardiopulmonary bypass caused a decrease in blood Mg concentration that persisted throughout the examination period ( (figure 1 ), table 1)( Tableau 1 ). The same changes were observed in group B, however Mg blood concentration in stage 1 was 0.75 mmol/L ( (figure 2) ). There were significant differences between these two groups in stages 1, 2 and 3 (table 1).

In group A, E increased from the stage 2 to 5 ( (figure 3) ) and similar changes were noted in group B ( (figure 4) ). There were significant differences between group A and B in stage 3 (table 1).

The NE level increased in both groups (figures 5 and 6), but higher blood concentrations were observed in group B (table 1). There were significant differences between group A and B in stage 2.

The Spearman correlation showed a significant relationship between Mg in stage 1 and E in stage 2, Mg and NE in stages 4 and 5 in group A. In group B significant relationship between Mg in stage 3 and E in stage 4, Mg and NE in stages 2 and 3 were observed (table 2)( Tableau 2 ).
Tableau 1 Magnesium, epinephrine and norepinephrine values in each stage.

Intergroup relationships – the comparison with first stage

Stages

1

2

3

4

5

Mg - group A

median

0.99

0.87***

0.89*

0.96***

0.98**

quartile 1

0.97

0.72

0.79

0.81

0.95

quartile 3

1.09

0.98

0.99

0.99

1

Mg – group B

median

0.78

0.59***

0.69*

0.90***

0.93**

quartile 1

0.70

0.48

0.64

0.79

0.73

quartile 3

0.79

0.68

0.75

0.99

0.99

E – group A

median

0.06

0.10**

0.09*

0.08*

0.08*

quartile 1

0.03

0.06

0.06

0.06

0.06

quartile 3

0.09

0.16

0.12

0.12

0.12

E – group B

median

0.06

0.12***

0.16***

0.09***

0.09***

quartile 1

0.04

0.09

0.10

0.07

0.08

quartile 3

0.07

0.20

0.20

0.11

0.12

NE – group A

median

0.08

0.09***

0.16***

0.22***

0.11*

quartile 1

0.06

0.08

0.11

0.12

0.07

quartile 3

0.11

0.21

0.35

0.74

0.24

NE – group B

median

0.11

0.24***

0.25***

0.24**

0.14*

quartile 1

0.09

0.16

0.16

0.13

0.09

quartile 3

0.18

0.37

0.60

0.97

0.79

The relationships between group A and B (Mann-Whitney U test)

Mg

A:B

p < 0.001

p < 0.001

p < 0.01

-

-

E

A:B

-

-

p < 0.01

-

-

NE

A:B

-

p < 0.01

-

-

-


Tableau 2 The Spearman correlation test.

N

R

Stages

Patients

Spearman

t(N-2)

p

Group A: magnesium and epinephrine

01:02

20

-0.54145

-2.73233

0.013678

Group A:magnesium and norepinephrine

02:02

20

-0.58503

-3.06043

0.006737

04:04

20

-0.54593

-2.76453

0.01277

04:05

20

-0.59774

-3.16332

0.005379

05:05

20

0.676971

3.902316

0.001044

Group B: magnesium and epinephrine

03:04

20

0.459744

2.196416

0.041403

Group B: magnesium and norepinephrine

02:02

20

-0.78947

-5.45705

3.49E-05

02:03

20

-0.69925

-4.14987

0.000602

02:05

20

-0.48815

-2.37301

0.028986

03:03

20

-0.57293

-2.96576

0.008279

Discussion

The effects of preoperative supplementation of Mg on its intra- and postoperative blood levels during ECC have not been explicitly documented in the literature. The lack of data on the advantages of such management in patients undergoing ECC procedures seems to point out the significance of observations undertaken. The complex character of ECC procedures as well as intra- and postoperative treatment used may significantly disturb the hormonal and electrolyte balance, although the relation between the E and NE concentration in blood and the Mg level is known and well documented in the literature [6-11]. Many researchers stress the strict correlation between the blood Mg and NE concentrations and myocardial insufficiency [10, 12]. This correlation was confirmed by Samejim et al. [10], who in their study on interrelations between concentrations of Mg and NE in the blood and myocardial insufficiency demonstrated the reverse relationship between the above-mentioned factors. According to Banfi et al. [13], the development of myocardial insufficiency is strictly connected to the activation of the neurohormonal system, and the production and release of NE, in particular. A drop in stroke volume and decrease in myocardial contraction cause an increase in the metalloprotein 2 level, leading to the accumulation of the above-mentioned substances in fibroblasts. Increased concentrations of these substances significantly limit the diastole of the myocardium contributing to further impairment of its function. Therefore many researchers believe that the blood NE concentration is a relevant diagnostic factor of myocardial insufficiency [9, 14, 15]. However, it is difficult to determine explicitly whether high levels of the hormone in question observed in our study caused myocardial insufficiency. Nevertheless, it is worth stressing that high NE levels were accompanied by a significant drop in blood Mg concentrations, which may confirm their relations as mentioned above.

Moreover, the “inotropically positive” action of Mg on the myocardium seems interesting and worth discussing. The Mg substitution-induced increased index of the left ventricle work [16] may result from the inhibitory effects of the element analyzed on the intracardiac secretion of NE [9] as well as from the inhibition of N type calcium receptors [17]. Significantly higher Mg levels were observed in our study in the group of patients receiving preoperative Mg supplementation and less frequent use of inotropically positive agents in this group seem to confirm the favourable effects of Mg on the myocardium, however, further observations are required to determine these relations explicitly. It should be also emphasized that preoperative supplementation of Mg deficiency may produce beneficial effects already before the initiation of the procedure discussed, since it is well known that high blood levels of this element reduce the reactivity of adrenals and nerve endings, which leads to easier stabilization of the circulatory system. Studying the blood E and NE concentrations in pigs receiving Mg preparations and standard diet before slaughter, D’Souza et al. [18] noted significantly lower NE values in animals with high blood Mg levels. A significantly higher content of muscle glycogen observed by the above authors in this group of animals and lower levels of muscle lactates at higher pH of the muscle cells should also be stressed. This fact seems to be extremely important in cardiosurgical patients, although precise cellular changes in such patients are unknown and their determination requires additional studies.

Preoperative supplementation of magnesium also has favourable effects on the adrenergic response of the organism during the procedure of endotracheal intubation. The increased blood concentrations of catecholamines observed during intubation [19-23] are dangerous, particularly in cardiac patients. This is confirmed by Puri et al. [24] who in their studies on haemodynamic disorders during intubation of patients undergoing surgical revascularization of the myocardium observed an increase in the stroke volume index without ST changes in patients receiving Mg infusions compared to the group without such infusions, in whom increased work of the myocardium was associated with significant EKG changes. Moreover, a smaller increase in mean arterial pressure and systemic vascular resistance in response to intubation is worth noticing. For these reasons the researchers conclude that Mg infusions have more beneficial effects stabilizing the cardiovascular system than lidocaine. Dube and Granry [2] also emphasize that preoperative Mg supplementation before induction of anaesthesia stabilizes the cardiovascular system and facilitates the control of the adrenergic response to intubation. The lower blood NE levels observed in our study in patients receiving Mg are in agreement with the data quoted, however the effects of high concentrations of this element on the haemodynamic changes during intubation require further observation. Nevertheless, it is worth stressing that in the group of patients receiving Mg, the initial (stage 1) concentration of NE was already lower, although the difference was not statistically significant. Therefore it may be assumed that preoperative Mg supplementation favourably affects the adrenergic response to intubation in patients undergoing surgical revascularization of the myocardium and should be the treatment of choice in such cases.

While analysing the effects of Mg supplementation, the antiarrhythmogenic action of this element should be stressed, particularly in the post-infusion period. Many researchers emphasize the dangers associated with hypomagnesemia in patients after ECC procedures [25-27]. This fact is likely to result from hypokaliemia accompanying low Mg levels [28, 29]. According to Whang and Ryder [28], low levels of potassium are related to blood Mg deficiencies in 61 % of cases and therefore potassium supplementation should be connected with Mg supply. According to Treggiari et al. [30], on the other hand, postoperative Mg substitution is ineffective for reducing artial fibrillation episodes, although low levels of the element in question predispose this pathology.

Another factor, which may induce perioperative arrhythmias, is likely to be a decrease in the myocardial arrhythmogenic threshold for E mentioned earlier [31]. It should be stressed that the high levels of E observed in our study in the postoperative period may favour arrhythmias in cases of hypomagnesemia, however, precise determination of these relations requires additional observation.

Furthermore, the analgesic effects of Mg seem interesting and important. In the recent years controversy has arisen and numerous clinical studies have been devoted to it [32-34]. It is thought that Mg has inhibitory effects (through affecting the calcium channels) on the brain’s NMDA receptors. According to Tramer et al. [34] and Telci et al. [35], this antagonistic action may limit the induction of the central sensitization by reducing the sensitivity of the peripheral receptors nociceptive to pain. For these reasons the patients receiving Mg require less morphine, less frequently complain of postoperative discomfort and sleep disorders, occurring in the first 48 hours after the administration of first doses of morphine. Similar advantages of Mg administration were demonstrated by Koining et al. [36]. They found the preoperative supply of this element significantly reduces the need for analgesics both during the surgical procedure and in the immediate postoperative period. Kara et al. [32] observed lower intra- and postoperative use of fentanyl and morphine in patients who received Mg during hysterectomy. Therefore it may seem that this element has definite analgesic effects. However, such effects of Mg are inconsistent with the observations by Ko et al. [33] who studied the Mg changes in the cerebro-spinal fluid during hysterectomy and found no significant Mg changes, although a difference in concentrations of this element was demonstrated in blood serum. The negative relation between the need for analgesics and Mg concentration in the cerebro-spinal fluid is also worth stressing. It should be also added that hysterectomy procedures are not the most painful ones, which might have affected the findings.

It is also difficult to determine the Mg analgesic activity in our cases as the procedures of surgical revascularization using the transsternal approach belong to the most stressful operations. Therefore, all the patients are administered high doses of analgesics in the postoperative period; moreover, combined anaesthesia (epidural and general) is used more and more commonly.

Discussing the effects of preoperative Mg substitution on homeostasis in ECC its beneficial effects on the intensification of postoperative apoptotic processes should also be emphasized as hypomagnesemia favours intensified processes of cell self-destruction. The main damaging mechanisms are thought to be disorders of the energetic balance of the cell resulting from low levels of this element [37-39] and effects of high blood concentrations of catecholamines, NE in particular [7]. The observed hypomagnesemia-induced dysfunction of the sodium-potassium pump and ATPase results in a decrease in intracellular potassium and elevation in calcium, which is likely to substantially limit the adaptative ability of the cell, particularly in stress situations. Such disorders also lead to reduced transmembranous potential in the mitochondria [37] causing the cell oedema. This is confirmed by the observations by Marcoccie et al. [37] who examined the causes of disorders of the transmembranous mitochondrial potential and observed low intracellular levels of Mg accompanied by the accumulation of calcium ions. It is difficult, however, to determine explicitly the direct effects of Mg substitution on the intensification of apoptosis of cells; nevertheless the recent reports increasingly stress the influence of extracorporeal circulation procedures on the process of their self-destruction [40]. Therefore, perioperative Mg substitution may seem right although further studies are required to determine its precise effects on apoptotic processes.

Conclusion

1) CABG with normovolemic haemodilution causes a decrease in blood magnesium concentration and an increase in blood adrenaline and norepinephrine concentrations.

2) Preoperative, oral supplementation of magnesium substantially reduces intra- and postoperative disorders of blood magnesium concentrations and significantly attenuates adrenergic response to operative stress.

References

1 Booth JV, Phillips-Bute B, McCants CB, Podgoreanu MV, Smith PK, Mathew PJ, Newman MF. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J 2003; 145: 1108-13.

2 Dube L, Granry JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anesth 2003; 50: 732-46.

3 Haigney MCP, Silver B, Tanglao E, Silverman HS, Shapiro E, Gerstenblith G, Schulman SP. Non-invasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995; 92: 2190-7.

4 Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616-22.

5 Nair RR, Nair P. Alteration of myocardial mechanics in marginal magnesium deficiency. Magnes Res 2002; 15: 287-306.

6 Polderman KH, Girbes ARJ. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care 2004; 8: R459-R466.

7 Delva P, Pastori C, Degan M, Montesi G, Lechi A. Catecholamine induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium. J Membr Biol 2004; 199: 163-71.

8 Malara A, Corsonello A, Buemi M, De Domenico D, Ientile R, Corica F. Effects of alpha- and beta-adrenergic stimulation on free magnesium concentrations in platelets from healthy and obese individuals. Magnes Res 2001; 14: 263-72.

9 Ohtsuka S, Oyake Y, Seo Y, Eda K, Yamaguchi I. Magnesium sulphate infusion suppresses the cardiac release of noradrenaline during a handgrip stress test. Can J Cardiol 2002; 18: 133-40.

10 Samejima H, Tanabe K, Suzuki N, Omiya K, Marayama M. Magnesium dynamics and sympathetic nervous system activity in patients with chronic heart failure. Jpn Circ J 1999; 63: 267-73.

11 Sameshima H, Tanaka S, Kamitomo M, Ikenoue T, Sakamoto H. Magnesium sulfate and fetal plasma concentrations of epinephrine, norepinephrine and vasopressin in response to acute hypoxemia in goats. J Soc Gynecol Investig 2000; 7: 328-32.

12 Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effest of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001; 22: 1136-43.

13 Banfi C, Cavalca V, Veglia F, Brioschi M, Barcella S, Mussoni L, Boccotti L, Tremoli E, Biglioli P, Agostini P. Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure. Eur Heart J 2005; 26: 481-8.

14 Benedictn CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690-7.

15 Rundqvist B, Elam M, Bergmann-Sverrisdotir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997; 95: 169-75.

16 Caspi J, Rudis E, Bar I, Safadi T, Saute M. Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995; 59: 942-7.

17 Shimosawa T, Takano K, Ando K, Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 2004; 44: 897-902.

18 D’Souza DN, Warner RD, Leury BJ, Dumshea FR. The effect of dietary magnesium asparate supplementation on pork quality. J Anim Sci 1998; 76: 104-9.

19 Baumgartner H, Sparr H, Ladner E, Haisjackl M. Catechlamine response to laryngoscopy and intubation: on the importance of sampling site. Anaesthesia 1993; 48: 359.

20 Brandt MR, Korshin J, Hansen PA, Hummer L, Madsen SN, Rygg I, Kehler H. Influence of morphine anaesthesia on the endocrine-metabolic response to open heart surgery. Acta Anaesth Scand 1978; 22: 400-12.

21 Crozier TA, Drobnik L, Stafforst D, Ketter D. Opiate modulation of the stress-induced increase of vasoactive intestinal peptide (VIP) in plasma. Horm Metab Res 1988; 20: 352-6.

22 Oczenski W, Krenn H, Dahaba AA, Binder M, El-Schhawi-Kienzl I, Jellinek H, Schwarz S, Fitzgerald RD. Hemodynamic and catecholamine stress responses to insertion of the Combitube, laryngeal mask airway or tracheal intubation. Anesth Analg 1999; 88: 1389-94.

23 Walsh ES, Peterson JL, O’Riordan JB, Hall GM. Effects of high-dose fentanyl anaesthesia on metabolic and endocrine response to cardiac surgery. Br J Anaesth 1981; 53: 1155.

24 Puri GD, Marudhachalm KS, Chari P, Suri RK. The effect of magnesium sulfate on hemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesth Analg 1998; 87: 808-11.

25 Toraman F, Karabulut EH, Alban HC, Dagden S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-61.

26 Zaman AG, Alagmir F, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1997; 77: 527-31.

27 Yeatman M, Caputo M, Narayan P, Lotto AA, Ascione R, Bryan AJ, Angelini GD. Magnesium supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 2002; 73: 112-8.

28 Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested versus routine. JAMA 1990; 263: 3063-4.

29 Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992; 152: 40-5.

30 Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter PM, Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000; 85: 690-5.

31 Crawford MW, Ho DS, Shams M, Gow R. Magnesium deficiency alters the threshold for epinephrine-induced arrythmias during halotane or sevoflurane anesthesia in rat. J Cardithorac Vasc Anesth 2004; 18: 313-6.

32 Kara H, Sahin N, Ulusan V, Aydogdu T. Magnesium infusion reduces perioperative pain. Eur J Anaesthesiol 2002; 19: 52-6.

33 Ko SH, Lim HR, Kim DC, Han YJ, Choe H, Song HS. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology 2001; 95: 640-6.

34 Tramer MR, Schneider J, Marti RA, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996; 84: 340-7.

35 Telci L, Esen F, Akcora D, Erden T, Canbolat AT, Akpir K. Evaluation of effects of magnesium sulphate in reducing intraoperative anaesthetic requirements. Br J Anaesth 2002; 89: 594-8.

36 Koining H, Wallner T, Marhofer P, Andel H, Hörauf K, Mayer N. Magnesium sulfate reduces intra and postoperative analgesic requirements. Anesth Analg 1998; 87: 206-10.

37 Marcocci L, Marchi U, Salvi M, Milella ZG, Nocera S, Agostinelli E, Mondovi B, Toninello A. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition. J Membr Biol 2002; 188: 23-31.

38 Rock E, Gueux E, Cubizolles C, Rayssiguier Y. Calcium permeability and ATPase activites of red blood cells of magnesium deficient rats. J Nutr Biochem 1995; 5: 351-5.

39 Lang F, Gulbins E, Szabo I, Leppe-Wienhues A, Huber SM, Duranton C, Lang KS, Lang PA, Wieder T. Cell volume and the regulation of apoptotic cell death. J Mol Recognit 2004; 17: 473-80.

40 Korycińska A, Dąbrowski W, Dragan M, Pożarowski P, Biernacka J, Stążka J, Roliński J. The degree of lymphocytic apoptosis during coronary artery bypass graft procedure and normovolemic haemodilution. Pol J Environ Stu 2005; 14: 223-7.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]